Vanguard Group’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.46M Buy
1,315,285
+549,293
+72% +$1.03M ﹤0.01% 3466
2025
Q1
$1.36M Hold
765,992
﹤0.01% 3613
2024
Q4
$2.42M Hold
765,992
﹤0.01% 3502
2024
Q3
$1.58M Hold
765,992
﹤0.01% 3629
2024
Q2
$1.12M Sell
765,992
-90,844
-11% -$133K ﹤0.01% 3756
2024
Q1
$2M Sell
856,836
-2,861
-0.3% -$6.7K ﹤0.01% 3592
2023
Q4
$1.74M Buy
859,697
+88,313
+11% +$178K ﹤0.01% 3651
2023
Q3
$3.73M Buy
771,384
+9,480
+1% +$45.9K ﹤0.01% 3366
2023
Q2
$5.21M Sell
761,904
-9,822
-1% -$67.2K ﹤0.01% 3278
2023
Q1
$5.59M Buy
771,726
+32,985
+4% +$239K ﹤0.01% 3249
2022
Q4
$9.48M Sell
738,741
-2,428
-0.3% -$31.2K ﹤0.01% 2969
2022
Q3
$10.5M Sell
741,169
-92,658
-11% -$1.31M ﹤0.01% 2935
2022
Q2
$10.3M Buy
833,827
+73,544
+10% +$906K ﹤0.01% 2978
2022
Q1
$12.9M Sell
760,283
-1,190
-0.2% -$20.2K ﹤0.01% 3017
2021
Q4
$18.4M Buy
761,473
+643,196
+544% +$15.5M ﹤0.01% 2883
2021
Q3
$3.47M Sell
118,277
-21
-0% -$617 ﹤0.01% 3854
2021
Q2
$3M Buy
118,298
+3,284
+3% +$83.3K ﹤0.01% 3838
2021
Q1
$2.23M Sell
115,014
-65,758
-36% -$1.27M ﹤0.01% 3838
2020
Q4
$2.66M Buy
180,772
+102,355
+131% +$1.5M ﹤0.01% 3587
2020
Q3
$1.76M Buy
78,417
+1,586
+2% +$35.7K ﹤0.01% 3522
2020
Q2
$1.44M Sell
76,831
-2,763
-3% -$51.8K ﹤0.01% 3523
2020
Q1
$657K Sell
79,594
-199
-0.2% -$1.64K ﹤0.01% 3611
2019
Q4
$746K Hold
79,793
﹤0.01% 3701
2019
Q3
$813K Sell
79,793
-6,933
-8% -$70.6K ﹤0.01% 3701
2019
Q2
$1.18M Buy
86,726
+7,250
+9% +$98.9K ﹤0.01% 3625
2019
Q1
$1.07M Buy
79,476
+27,674
+53% +$374K ﹤0.01% 3609
2018
Q4
$1.32M Sell
51,802
-20,068
-28% -$512K ﹤0.01% 3485
2018
Q3
$3.33M Buy
+71,870
New +$3.33M ﹤0.01% 3370